Fortis Hospital Nagarbhavi successfully treated a 72-year-old-man for a rare and aggressive bladder cancer known as ‘squamous ...

The leading Cutaneous Squamous Cell Carcinoma Companies such as Incyte Corporation, Shanghai Henlius Biotech, Novartis, ...

Metformin is a medication prescribed to help manage type 2 diabetes. Recent research suggests, however, this medication may ...

Keytruda demonstrated a statistically significant and clinically meaningful improvement in event-free survival and major ...

KEYTRUDA monotherapy is the recommended first-line treatment for recurrent or metastatic HNSCC with high PD-L1 expression, ...

The FDA granted priority review to pembrolizumab for neoadjuvant and adjuvant use in head and neck squamous cell carcinoma, ...

Skin Cancer is the most common cancer in the United States, with an estimated one in five Americans expected to develop skin ...

The US Food and Drug Administration (FDA) has granted fast track designation to Pyxis Oncology’s antibody-drug conjugate (ADC ...

A new clinical guideline from the American Society for Radiation Oncology (ASTRO) provides guidance on the use of radiation ...

Beth Riehle tells PEOPLE how on March 11, 2024, she was diagnosed with squamous cell carcinoma, the most common form of tongue cancer.

A biopsy reveals squamous cell carcinoma (SCC) in situ. What should be the next steps in the patient's evaluation and management? After the initial consultation, the patient's biopsy specimen was ...

for pembrolizumab (Keytruda ®) for the treatment of patients with resectable locally advanced head and neck squamous cell carcinoma (LA-HNSCC) as neoadjuvant treatment, then continued as adjuvant ...